
- Pharmaceutical Executive-09-01-2002
Dutch Government Just Says No
Spurred by concerns about rising drug expenditures, the Netherlands' government has introduced a list of "lifestyle" medicines that it intends to stop covering with its basic health insurance.
Spurred by concerns about rising drug expenditures, the Netherlands' government has introduced a list of "lifestyle" medicines that it intends to stop covering with its basic health insurance. It believes it should not have to pay for medi-cines for conditions brought on by unhealthy lifestyles, such as smoking and poor diet.
But plans to include cholesterol-reducing products on the list have worried the College voor Zorgverzekeringen (the Healthcare Insurance Board) which advises the government. The board has issued a report on statins, saying that their use should remain a part of basic health insurance because of their long-term preventive benefits.
Articles in this issue
about 23 years ago
Pharmaceutical Innovation Under Attackabout 23 years ago
More Statins = Fewer Heart Attacksabout 23 years ago
When Worlds Collideabout 23 years ago
Top European Trial Sponsorsabout 23 years ago
Novo Nordisk Cancels Clinical Trialsabout 23 years ago
Lilly Marketers Cross the Lineabout 23 years ago
Spending Hits a Wallabout 23 years ago
Strangers in the Shadowsabout 23 years ago
Plants and Patentsabout 23 years ago
Industry Audit & Companies of the YearNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





